Evaluating Shared Decision Making for Lung Cancer Screening

JAMA Internal Medicine

Volumn 178, Issue 10, 2018, Pages 1311-1316

  Brenner, Alison T ^a,b   Malo, Teri L ^b   Margolis, Marjorie ^c   Elston Lafata, Jennifer ^b,d   James, Shynah ^c   Vu, Maihan B ^b,c   Reuland, Daniel S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

^d University of North Carolina   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; DECISION MAKING; DECISION SUPPORT SYSTEM; EARLY CANCER DIAGNOSIS; FEMALE; HUMAN; LUNG TUMOR; MALE; MEDICARE; MIDDLE AGED; PATIENT PARTICIPATION; UNITED STATES;

AGED; DECISION MAKING; DECISION SUPPORT TECHNIQUES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MEDICARE; MIDDLE AGED; PATIENT PARTICIPATION; UNITED STATES;

EID: 85054448993     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2018.3054     Document Type: Article

References (23)

1. Moyer VA; US Preventive Services Task Force. Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 160 (5): 330-338. doi: 10.7326/M13-2771 24378917
2. Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013; 119 (7): 1381-1385. doi: 10.1002/cncr.27813 23440730
3. Bach PB, Mirkin JN, Oliver TK, Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307 (22): 2418-2429. doi: 10.1001/jama.2012.5521 22610500
4. Harris RP, Sheridan SL, Lewis CL, The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med. 2014; 174 (2): 281-285. doi: 10.1001/jamainternmed.2013.12745 24322781
5. Patz EFJ Jr, Pinsky P, Gatsonis C,; NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014; 174 (2): 269-274. doi: 10.1001/jamainternmed.2013.12738 24322569
6. Wood DE. The importance of lung cancer screening with low-dose computed tomography for Medicare beneficiaries. JAMA Intern Med. 2014; 174 (12): 2016-2018. doi: 10.1001/jamainternmed.2014.5623 25317992
7. Woolf SH, Harris RP, Campos-Outcalt D. Low-dose computed tomography screening for lung cancer: how strong is the evidence? JAMA Intern Med. 2014; 174 (12): 2019-2022. doi: 10.1001/jamainternmed.2014.5626 25317533
8. Centers for Medicare & Medicaid Services. Decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=274. Published February 5, 2015. Accessed April 16, 2018.
9. Goff SL, Mazor KM, Ting HH, Kleppel R, Rothberg MB. How cardiologists present the benefits of percutaneous coronary interventions to patients with stable angina: a qualitative analysis. JAMA Intern Med. 2014; 174 (10): 1614-1621. doi: 10.1001/jamainternmed.2014.3328 25156523
10. Elwyn G, Hutchings H, Edwards A, The OPTION scale: measuring the extent that clinicians involve patients in decision-making tasks. Health Expect. 2005; 8 (1): 34-42. doi: 10.1111/j.1369-7625.2004.00311.x 15713169
11. Elwyn G, Edwards A, Wensing M, Grol R. OPTION rater manual. http://www.optioninstrument.org/uploads/2/4/0/4/24040341/option-12-rater-manual.pdf. Accessed April 14, 2018.
12. Rapport F, Wainwright P, Elwyn G. "Of the edgelands": broadening the scope of qualitative methodology. Med Humanit. 2005; 31 (1): 37-42. doi: 10.1136/jmh.2004.000190 23674648
13. Hoffman RM, Couper MP, Zikmund-Fisher BJ, Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Arch Intern Med. 2009; 169 (17): 1611-1618. doi: 10.1001/archinternmed.2009.262 19786681
14. Hoffmann TC, Del Mar C. Patients' expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2015; 175 (2): 274-286. doi: 10.1001/jamainternmed.2014.6016 25531451
15. Hoffmann TC, Del Mar C. Clinicians' expectations of the benefits and harms of treatments, screening, and tests: a systematic review. JAMA Intern Med. 2017; 177 (3): 407-419. doi: 10.1001/jamainternmed.2016.8254 28097303
16. Couët N, Desroches S, Robitaille H, Assessments of the extent to which health-care providers involve patients in decision making: a systematic review of studies using the OPTION instrument. Health Expect. 2015; 18 (4): 542-561. doi: 10.1111/hex.12054 23451939
17. Légaré F, Stacey D, Turcotte S, Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2014;(9): CD006732. 25222632
18. Reuland DS, Cubillos L, Brenner AT, Harris RP, Minish B, Pignone MP. A pre-post study testing a lung cancer screening decision aid in primary care. BMC Med Inform Decis Mak. 2018; 18 (1): 5. doi: 10.1186/s12911-018-0582-1 29325548
19. Volk RJ, Linder SK, Leal VB, Feasibility of a patient decision aid about lung cancer screening with low-dose computed tomography. Prev Med. 2014; 62: 60-63. doi: 10.1016/j.ypmed.2014.02.006 24518006
20. Lau YK, Caverly TJ, Cao P, Evaluation of a personalized, web-based decision aid for lung cancer screening. Am J Prev Med. 2015; 49 (6): e125-e129. doi: 10.1016/j.amepre.2015.07.027 26456873
21. Jimbo M, Rana GK, Hawley S, What is lacking in current decision aids on cancer screening? CA Cancer J Clin. 2013; 63 (3): 193-214. doi: 10.3322/caac.21180 23504675
22. Mazzone PJ, Tenenbaum A, Seeley M, Impact of a lung cancer screening counseling and shared decision-making visit. Chest. 2017; 151 (3): 572-578. doi: 10.1016/j.chest.2016.10.027 27815154
23. Mazzone PJ, Silvestri GA, Patel S, Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2018; 153 (4): 954-985. doi: 10.1016/j.chest.2018.01.016 29374513